Bronwyn Long
Papers
1
Total Citations
2
H-Index
1
About
Dr. Bronwyn Long is a leading urological researcher whose work centers on minimally invasive treatments for benign prostatic hyperplasia (BPH). Her most-cited paper, "UroLift, Rezūm, and iTind for Benign Prostatic Hyperplasia" (2025), provides a critical comparative analysis of three cutting-edge procedures—UroLift, Rezūm, and iTind—that are reshaping the management of lower urinary tract symptoms. This work synthesizes emerging evidence on efficacy, safety, and patient outcomes, offering clinicians a practical framework for selecting individualized therapies. While still early in its citation trajectory, the paper has already garnered 2 citations, signaling its growing influence in the field. Dr. Long’s contributions are particularly notable for bridging the gap between novel technologies and real-world clinical decision-making, helping to reduce the reliance on more invasive surgeries. Her research underscores a commitment to improving quality of life for millions of men worldwide. As a rising voice in urology, Dr. Long continues to advance the conversation around patient-centered, office-based treatments, making her a key figure to watch in the evolution of BPH care.
Research Focus
Key Achievements
Top Papers
- 1UroLift, Rezūm, and iTind for Benign Prostatic Hyperplasia2 citations · 2025